STEMI多支病变完全血运重建与仅罪犯病变PCI对心绞痛相关生活质量的影响:COMPLETE随机临床试验结果
该研究为COMPLETE随机试验的二次分析,纳入4041例STEMI合并多支CAD患者,比较完全血运重建与仅罪犯病变PCI对心绞痛相关健康状况的影响。
要点
- STEMI多支病变患者完全血运重建较仅罪犯病变PCI轻度提高无 angina 比例(87.5% vs 84.3%)。
- SAQ-AF评分组间差异仅0.97分,临床意义有限,但为额外健康状态获益。
- 非罪犯病变狭窄≥80%的患者从完全血运重建中获益更明显。
核心结论
- 在STEMI合并多支CAD患者中,完全血运重建较仅罪犯病变PCI使无 angina 患者比例轻度增加。
- 该健康状态改善幅度有限,但为完全血运重建减少心血管事件的已确立获益之外的额外好处。
研究设计与样本
- 研究为随机、跨国、开放标签试验的患者报告结局二次分析,共纳入4041例STEMI合并多支CAD患者。
- 患者随机接受完全血运重建(额外PCI处理血管造影显著的非罪犯病变)或仅罪犯病变PCI,中位随访3年。
临床怎么用
- 对于STEMI合并多支CAD患者,完全血运重建可在减少心血管事件基础上轻度改善心绞痛相关健康状态。
- 非罪犯病变狭窄≥80%的患者可能从完全血运重建中获得更明显的无 angina 获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In patients with multivessel coronary artery disease (CAD) presenting with ST-segment elevation myocardial infarction (STEMI), complete revascularization reduces major cardiovascular events compared with culprit lesion-only percutaneous coronary intervention (PCI). Whether complete revascularization also improves angina-related health status is unknown. OBJECTIVE: To determine whether complete revascularization improves angina status in patients with STEMI and multivessel CAD. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a randomized, multinational, open label trial of patient-reported outcomes took place in 140 primary PCI centers in 31 countries. Patients presenting with STEMI and multivessel CAD were randomized between February 1, 2013, and March 6, 2017. Analysis took place between July 2021 and December 2021. INTERVENTIONS: Following PCI of the culprit lesion, patients with STEMI and multivessel CAD were randomized to receive either complete revascularization with additional PCI of angiographically significant nonculprit lesions or to no further revascularization. MAIN OUTCOMES AND MEASURES: Seattle Angina Questionnaire Angina Frequency (SAQ-AF) score (range, 0 [daily angina] to 100 [no angina]) and the proportion of angina-free individuals by study end. RESULTS: Of 4041 patients, 2016 were randomized to complete revascularization and 2025 to culprit lesion-only PCI. The mean (SD) age of patients was 62 (10.7) years, and 3225 (80%) were male. The mean (SD) SAQ-AF score increased from 87.1 (17.8) points at baseline to 97.1 (9.7) points at a median follow-up of 3 years in the complete revascularization group (score change, 9.9 [95% CI, 9.0-10.8]; P < .001) compared with an increase of 87.2 (18.4) to 96.3 (10.9) points (score change, 8.9 [95% CI, 8.0-9.8]; P < .001) in the culprit lesion-only group (between-group difference, 0.97 points [95% CI, 0.27-1.67]; P = .006). Overall, 1457 patients (87.5%) were free of angina (SAQ-AF score, 100) in the complete revascularization group compared with 1376 patients (84.3%) in the culprit lesion-only group (absolute difference, 3.2% [95% CI, 0.7%-5.7%]; P = .01). This benefit was observed mainly in patients with nonculprit lesion stenosis severity of 80% or more (absolute difference, 4.7%; interaction P = .02). CONCLUSIONS AND RELEVANCE: In patients with STEMI and multivessel CAD, complete revascularization resulted in a slightly greater proportion of patients being angina-free compared with a culprit lesion-only strategy. This modest incremental improvement in health status is in addition to the established benefit of complete revascularization in reducing cardiovascular events.
引用
- Mehta, Wang, Wood, et al. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. JAMA Cardiol. 2022. PMID: 36129696. doi:10.1001/jamacardio.2022.3032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。